Slowing the Progression of Renal Disease in Patients with Diabetes Mellitus

Abstract

Get full access to this article

View all access options for this article.

References

Vivian

, Goebig

. Slowing the progression of renal disease in diabetic patients. Ann Pharmacother 2001; 35: 452-63.

Brenner

, Cooper

, Zeeuw

, Keane

, Mitch

, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861-9.

Lewis

, Hunsicker

, Clarke

, Berl

, Pohl

, Lewis

et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001; 345: 851-60.

Viberti

, Wheeldon

. Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus. Circulation 2002; 106: 672-8.

American Diabetes Association. Diabetic nephropathy. Diabetes Care 2002; 25 (supp 1): S85-9.